Overview

A Study of Alvimopan for the Management of Postoperative Ileus in Participants Undergoing Radical Cystectomy

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to determine whether alvimopan can accelerate recovery of gastrointestinal function following radical cystectomy when compared with a placebo. Secondary objectives of the study are: - to evaluate the effect of alvimopan on hospital length of stay - to evaluate the effect of alvimopan on prespecified postoperative ileus (POI)-related morbidities - to evaluate the overall and cardiovascular safety of alvimopan
Phase:
Phase 4
Details
Lead Sponsor:
Cubist Pharmaceuticals LLC
Treatments:
Alvimopan